This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Designing an IHC experiment for SV2C? The guide has the expected staining pattern, antigen retrieval and fixation, antibodies backed by real IHC images, the tissue controls to run alongside, and protocols taken from published papers.
Open the SV2C IHC GuideFacts about Synaptic vesicle glycoprotein 2C.
.
| Human | |
|---|---|
| Gene Name: | SV2C |
| Uniprot: | Q496J9 |
| Entrez: | 22987 |

| Belongs to: |
|---|
| major facilitator superfamily |

KIAA1054; MGC118874; MGC118875; MGC118876; MGC118877; SV2C; synaptic vesicle glycoprotein 2C; synaptic vesicle protein 2C
Mass (kDA):
82.342 kDA

| Human | |
|---|---|
| Location: | 5q13.3 |
| Sequence: | 5; NC_000005.10 (75847463..76353939) |
Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Multi-pass membrane protein. Enriched in small synaptic vesicles and adrenal microsomes, not present in chromaffin granules. Associated with both insulin granules and synaptic-like microvesicles in insulin-secreting cells of the pancreas.




PMID: 21483489 by Peng L., et al. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
PMID: 27313224 by Mahrhold S., et al. Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1.